Table 3:
Distribution of the different components of the augmented comorbidity/age index among the three donor groups.
| HLA-MM (n=345) | UCB (n=262) | Haplo (n=117) | |
|---|---|---|---|
| Augmented comorbidity/age index components | % (n) | % (n) | % (n) |
| Arrhythmia | 6 (20) | 5(12) | 7(8) |
| Cardiac | 10(33) | 7(18) | 8(9) |
| Inflammatory bowel disease | 0.2(1) | 0.7(2) | 0.9(1) |
| Diabetes | 8(29) | 7(19) | 5(6) |
| Cerebrovascular disease | 4(14) | 4(10) | 3(3) |
| Psychiatric disturbance | 21(71) | 15(40) | 23(27) |
| Hepatic, mild | 12(40) | 18(49) | 14(16) |
| Obesity | 7(25) | 6(16) | 8(9) |
| Infection | 22(76) | 35(93) | 26(30) |
| Rheumatologic | 0.6(2) | 2(5) | 0 |
| Peptic ulcer | 2(8) | 2(4) | 3(3) |
| Moderate/severe renal | 0.9(3) | 0.8(2) | 3(3) |
| Moderate pulmonary | 35(122) | 33(86) | 37(44) |
| Prior malignancy | 10(36) | 9(24) | 9(10) |
| Heart valve disease | 1(4) | 2(6) | 2(2) |
| Severe pulmonary | 16(56) | 16(43) | 26(31) |
| Moderate/severe hepatic | 3(11) | 3(7) | 0.9(1) |
| High ferritin | 3 (11) | 3 (8) | 8 (9) |
| Mild Hypoalbuminemia | 14 (50) | 11 (29) | 25 (29) |
| Moderate hypoalbuminemia | 7 (23) | 4 (11) | 6 (7) |
| Thrombocytopenia | 44 (152) | 30 (79) | 49 (57) |
| Age ≥40 years | 62 (215) | 39 (101) | 55 (64) |